QR-koodi

Convalescent Plasma for Hospitalized COVID-19 Patients: A Single-Center Experience

In Winter 2020, Italy, and in particular the Lombardy region, was the first country in the Western hemisphere to be hit by the COVID-19 pandemic. Plasma from individuals recovered from COVID-19 (COVID-19 convalescent plasma, CCP) was the first therapeutic tool adopted to counteract the severe acute...

Täydet tiedot

Tallennettuna:
Päätekijät: Massimo Franchini, Claudia Glingani, Giuseppe De Donno, Giuseppe Lucchini, Massimiliano Beccaria, Massimo Amato, Gian Paolo Castelli, Leonardo Bianciardi, Mauro Pagani, Marco Ghirardini, Giuseppe Puma, Barbara Presciuttini, Maria Teresa Costantino, Marilena Frigato, Verena Crosato, Giorgio Tiecco, Alice Mulè, Dorothea Angela Papalia, Francesco Inglese, Fabio Spreafico, Martina Garuti, Antonietta Pecoriello, Giulia Cervi, Graziana Greco, Vanni Galavotti, Tiziana Santini, Angela Berselli, Carlo Montalto, Riccardo Bertoletti, Simona Aurelia Bellometti, Enrico Capuzzo, Dario Benazzi, Gianpaolo Grisolia, Fabio Pajola, Raffaello Stradoni, Matteo Zani, Adriano Verzola, Vito Codeluppi, Silvia Vesentini, Elisa Bellocchio, Marco Candini, Giorgina Ambrosi, Francesca Carandina, Cleante Scarduelli, Albino Reggiani, Salvatore Casari, on behalf of Convalescent Plasma Study Group
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI AG 2022-03-01
Sarja:Life
Aiheet:
COVID-19
convalescent plasma
mortality
safety
Linkit:https://www.mdpi.com/2075-1729/12/3/420
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia